Related Experiment Video
Updated: Aug 14, 2026

Semi-Quantitative Analysis of Peptidoglycan by Liquid Chromatography Mass Spectrometry and Bioinformatics
Published on: October 13, 2020
Peptidoglycan recognition proteins are a new class of human bactericidal proteins
Xiaofeng Lu1, Minhui Wang, Jin Qi
1Indiana University School of Medicine-Northwest, Gary, IN 46408, USA.
Abstract:
Skin and mucous membranes come in contact with external environment and protect tissues from infections by producing antimicrobial peptides. We report that human peptidoglycan recognition proteins 3 and 4 (PGLYRP3 and PGLYRP4) are secreted as 89-115-kDa disulfide-linked homo- and heterodimers and are bactericidal against several pathogenic and nonpathogenic transient, but not normal flora, Gram-positive bacteria. PGLYRP3 and PGLYRP4 are also bacteriostatic toward all other tested bacteria, which include Gram-negative bacteria and normal flora Gram-positive bacteria. PGLYRP3 and PGLYRP4 are also active in vivo and protect mice against experimental lung infection. In contrast to antimicrobial peptides, PGLYRPs kill bacteria by interacting with their cell wall peptidoglycan, rather than permeabilizing their membranes. PGLYRP3 and PGLYRP4 are expressed in the skin, eyes, salivary glands, throat, tongue, esophagus, stomach, and intestine. Thus, we have identified the function of mammalian PGLYRP3 and PGLYRP4, and show that they are a new class of bactericidal and bacteriostatic proteins that have different structures, mechanism of actions, and expression patterns than antimicrobial peptides.
Insights
Human peptidoglycan recognition proteins 3 and 4 (PGLYRP3 and PGLYRP4) are new antimicrobial proteins. They kill Gram-positive bacteria by targeting cell walls and protect against lung infections in mice.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Skin and mucous membranes are crucial barriers against infection.
- Antimicrobial peptides are key components of innate immunity.
- The function of mammalian peptidoglycan recognition proteins (PGLYRPs) was previously unclear.
Purpose of the Study:
- To elucidate the function and mechanism of action of human PGLYRP3 and PGLYRP4.
- To determine if PGLYRP3 and PGLYRP4 possess antimicrobial activity.
- To investigate the in vivo efficacy and expression patterns of PGLYRP3 and PGLYRP4.
Main Methods:
- Characterization of secreted PGLYRP3 and PGLYRP4 structure (homo- and heterodimers).
- Assessment of bactericidal and bacteriostatic activity against various Gram-positive and Gram-negative bacteria.
- In vivo studies using a mouse model of experimental lung infection.
- Analysis of PGLYRP3 and PGLYRP4 expression in different human tissues.
Main Results:
- PGLYRP3 and PGLYRP4 are secreted as disulfide-linked dimers (89-115 kDa).
- They exhibit bactericidal activity against transient Gram-positive bacteria and bacteriostatic activity against all other tested bacteria.
- PGLYRP3 and PGLYRP4 protect mice against lung infection.
- Mechanism involves interaction with bacterial peptidoglycan, not membrane permeabilization.
- Expression is detected in skin, eyes, and various mucosal tissues.
Conclusions:
- Mammalian PGLYRP3 and PGLYRP4 represent a novel class of antimicrobial proteins.
- They possess distinct structures, mechanisms of action, and expression patterns compared to antimicrobial peptides.
- These proteins play a significant role in innate immunity and host defense against bacterial infections.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Peptidoglycan Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Bacterial Toxins
Bacterial Cell Wall
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
